Why the study?
Does implantable cardioverter-defibrillator (ICD) therapy reduce mortality in post-myocardial infarction patients with reduced ejection fraction?
Does implantable cardioverter-defibrillator (ICD) therapy reduce mortality in post-myocardial infarction patients with reduced ejection fraction?
This editorial advocates for expanding UK NICE guidelines to allow primary prevention ICD implantation in post-MI patients based on non-invasive risk stratification.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
John M. Morgan (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: